B7-H3 as a Therapeutic Target in Advanced Prostate Cancer (2023)
Attributed to:
BAG-1: A novel strategy for targeting the androgen receptor splice variants in castrate resistant prostate cancer.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.eururo.2022.09.004
PubMed Identifier: 36114082
Publication URI: http://europepmc.org/abstract/MED/36114082
Type: Journal Article/Review
Parent Publication: European Urology
Issue: 3
ISSN: 0302-2838